Its current phase 2a study compares MOTS-c with placebo, not tirzepatide, so no known interaction is not evidence that the stack is compatible
The mesolimbic reward system represents a third mechanism through which GLP-1 affects eating behavior
* Results may vary based on adherence, medical condition, baseline weight, and lifestyle factors
10.1073/pnas.1221055110 55 HolmanR
Moreover the duration of the L-carnitine supplementation differs from one study to another, therefore further studies are required to test the time dependence of the observed effect as well as the impact of L-carnitine bioavailability on the Lp(a)-lowering activity
Lipid Panel: Cholesterol and Triglycerides What it measures: Total cholesterol, LDL (bad cholesterol), HDL (good cholesterol), and triglycerides